BIFIDO Co. Ltd

BIFIDO Co. Ltd

238200 · KQ · Consumer Defensive / Packaged Foods

2,360.00KRW-20.00 (-0.84%)

Price History

Full chart

Market Stats

Previous Close2,380.00
Open2,380.00
Day Range2,210.00 – 2,380.00
52-Week Range2,045.00 – 4,300.00
Volume18.16K
Market Cap21.51B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.94
50-Day Avg2,645.10
200-Day Avg2,789.70

About

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Myeongsoo Park
  • Employees0
  • Headquarters23-16 Nonggongdanji-gil, Hongcheon-eup, South Korea, Korea
  • Websitehttps://www.bifido.com

Leadership

  • Mr. Myeongsoo ParkCo-Chief Executive Officer · b. 1970
  • Yong-chul ShinCo-Chief Executive Officer

Financials

Income Statement

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue12.07B13.66B14.87B13.01B12.38B12.12B14.58B18.63B12.35B19.68B
Growth (%)-+13.21%+8.83%-12.49%-4.86%-2.13%+20.32%+27.82%-33.72%+59.34%
Cost of Revenue7.42B8.04B8.15B7.55B7.91B7.98B8.72B11.21B9.07B12.19B
Gross Profit4.65B5.62B6.72B5.46B4.47B4.13B5.86B7.42B3.28B7.49B
Gross Margin38.52%41.15%45.21%41.96%36.13%34.13%40.21%39.83%26.60%38.06%
Operating Expense2.55B2.61B3.24B4.08B5.39B5.21B4.61B7.77B7.78B6.09B
Operating Income2.09B3.02B3.48B1.38B-911.58M-1.07B1.26B-343.65M-4.49B1.40B
Operating Margin17.35%22.08%23.43%10.63%-7.36%-8.87%8.61%-1.84%-36.37%7.13%
EBITDA------3.56B2.28B-4.15B1.87B
EBITDA Margin------24.39%12.21%-33.60%9.52%
Net Income2.17B2.43B1.13B1.58B-552.82M4.49B1.55B1.08B-5.40B-192.74M
Net Income Margin17.97%17.75%7.61%12.16%-4.47%37.08%10.60%5.81%-43.69%-0.98%
R&D---512.49M991.03M948.83M1.07B1.50B2.87B1.61B
R&D as % of Total Revenue---3.94%8.00%7.83%7.37%8.03%23.24%8.17%
Interest Expense0007.78M8.89M9.61M13.51M263.73M737.79M402.65M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.06%0.07%0.08%0.09%1.42%5.97%2.05%

Balance Sheet

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets34.34B36.85B46.74B48.24B51.30B54.65B54.94B71.74B61.21B61.30B
Total Liabilities18.27B18.35B2.01B1.95B6.70B4.01B2.45B20.03B14.53B15.37B
Total Equity16.07B18.50B44.73B46.29B44.60B50.64B52.49B51.70B46.69B45.93B
Cash-6.89K-2.16B8.41B1.71M365.02M5.81B1.76B7.66B
Total Debt---58.28M113.97M-----
Net Debt-------5.57B8.94B4.34B

Cash Flow

Currency: KRW2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.34B3.86B4.75B2.65B1.87B2.04B1.88B2.85B-716.29M3.95B
Investing Cash Flow-8.73B-3.25B-18.93B-4.66B2.43B-4.31B-5.42B---
Financing Cash Flow11.99B06.69B-71.29M-1.26B1.54B-134.82M---
Capital Expenditure2.63B1.25B2.14B18.98B2.78B14.63B1.05B3.34B6.12B7.24B
Free Cash Flow----15.09B-1.06B-12.68B776.05M-489.65M-6.83B-3.29B
FCF to OCF----569.33%-56.58%-622.56%41.38%-17.19%954.10%-83.39%

Earnings

Report DateFeb 28, 2019May 15, 2019Aug 14, 2019Nov 29, 2019Feb 27, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------
EPS Actual62.4049.47114.7317.3711.8339.35-0.93-61.43-46.30695.49-21.97-45.85-69.7581.8417.21108.78-18.88-29.7110.4338.6396.94-132.40-213.03-196.58-118.3322.7792.65-27.24-111.74-184.2038.84
Surprise-------------------------------
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--------------------------

Key Statistics & Ratios

Market Cap21.51B
Enterprise Value24.16B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.47
Price / Book0.44
Revenue (TTM)14.63B
Gross Profit (TTM)4.59B
EBITDA763.22M
Profit Margin12.64%
Operating Margin-11.39%
Return on Equity3.83%
Return on Assets-0.95%
Shares Outstanding8.18M
Shares Float5.21M
Beta0.94
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Apr 1, 20212:1